1.Raise awareness of targeting inflammation in DKD by Phosphodiesterases (PDEs).
2.Review the etiology of DKD.
3.Explore how PTX could be beneficial in patients unable to tolerate RAAS blockade.
Thursday, January 9, 2020 - 1:00pm to 2:00pm
Dr. David Leehey
5700 S Maryland Ave
Chicago, IL 60637
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation